Literature DB >> 21360515

Increased levels of interleukin-27 in patients with rheumatoid arthritis.

Hui Shen1, Liping Xia, Weiguo Xiao, Jing Lu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21360515     DOI： 10.1002/art.30180

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  14 in total

Review 1.  IL-27: a double agent in the IL-6 family.

Authors:  G W Jones; D G Hill; A Cardus; S A Jones
Journal:  Clin Exp Immunol       Date:  2018-03-09       Impact factor: 4.330

2.  Elevated serum level of IL-27 and VEGF in patients with ankylosing spondylitis and associate with disease activity.

Authors:  Tian-Tian Lin; Jing Lu; Chen-Yue Qi; Lin Yuan; Xiao-Lin Li; Li-Ping Xia; Hui Shen
Journal:  Clin Exp Med       Date:  2014-04-08       Impact factor: 3.984

3.  Altered peripheral B lymphocyte homeostasis and functions mediated by IL-27 via activating the mammalian target of rapamycin signaling pathway in patients with rheumatoid arthritis.

Authors:  Yawei Tang; Ziran Bai; Jingjing Qi; Zhimin Lu; Guan Wang; Minli Jin; Bing Wang; Haifeng Chen; Xia Li
Journal:  Clin Exp Immunol       Date:  2021-10-05       Impact factor: 4.330

4.  Elevated serum and synovial fluid levels of interleukin-34 in rheumatoid arthritis: possible association with disease progression via interleukin-17 production.

Authors:  Ye Tian; Hui Shen; Liping Xia; Jing Lu
Journal:  J Interferon Cytokine Res       Date:  2013-02-19       Impact factor: 2.607

Review 5.  Interleukin-27 as a potential therapeutic target for rheumatoid arthritis: has the time come?

Authors:  Fang Gong; Yu-Hong Pan; Xuan Huang; Jiang Chen; Jin-Hua Xiao; Hua-Yan Zhu
Journal:  Clin Rheumatol       Date:  2013-07-23       Impact factor: 2.980

Review 6.  Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases.

Authors:  Daniella M Schwartz; Michael Bonelli; Massimo Gadina; John J O'Shea
Journal:  Nat Rev Rheumatol       Date:  2015-12-03       Impact factor: 20.543

7.  Decreased serum interleukin 27 in Brazilian systemic lupus erythematosus patients.

Authors:  Angela Luzia Branco Pinto Duarte; Andréa Tavares Dantas; Henrique de Ataíde Mariz; Flaviana Alves dos Santos; Juliana Cruz da Silva; Laurindo Ferreira da Rocha; Suely Lins Galdino; Maira Galdino da Rocha Pitta
Journal:  Mol Biol Rep       Date:  2013-05-06       Impact factor: 2.316

8.  Increased Frequency of T Follicular Helper Cells and Elevated Interleukin-27 Plasma Levels in Patients with Pemphigus.

Authors:  Tina Hennerici; Robert Pollmann; Thomas Schmidt; Maria Seipelt; Björn Tackenberg; Christian Möbs; Kamran Ghoreschi; Michael Hertl; Rüdiger Eming
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

Review 9.  Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis.

Authors:  Zhu Chen; Aline Bozec; Andreas Ramming; Georg Schett
Journal:  Nat Rev Rheumatol       Date:  2019-01       Impact factor: 20.543

10.  Plasma interleukin-27 (IL-27) levels are not modulated in patients with chronic HIV-1 infection.

Authors:  Sanjay Swaminathan; Zonghui Hu; Adam W Rupert; Jeanette M Higgins; Robin L Dewar; Randy Stevens; Qian Chen; Catherine A Rehm; Julia A Metcalf; Michael W Baseler; H Clifford Lane; Tomozumi Imamichi
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.